TAZVERIK® (tazemetostat) | R/R Follicular Lymphoma and …
TAZVERIK® (tazemetostat) is a prescription medicine for adults with relapsed or refractory follicular lymphoma or advanced epithelioid sarcoma. See Important Safety Information and full Prescribing Information, including Medication Guide.
TAZVERIK® (tazemetostat) HCP | R/R Follicular Lymphoma
TAZVERIK® (tazemetostat) is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma. Review efficacy and safety data, dosing, or contact a rep. See Important Safety Information and full Prescribing Information, including Medication Guide.
How TAZVERIK® (tazemetostat) Works for Advanced Epithelioid …
TAZVERIK ® is a prescription medicine used to treat adults and children aged 16 years and older with epithelioid sarcoma that has spread or grown and cannot be removed by surgery. The approval of TAZVERIK in these patients is based on a study that measured the percentage of patients whose tumor shrank or disappeared after treatment and how ...
TAZVERIK® (tazemetostat) | How TAZVERIK Works for R/R …
TAZVERIK is FDA approved to treat relapsed or refractory follicular lymphoma. See Important Safety Information and full Prescribing Information, including Medication Guide. How TAZVERIK® (tazemetostat) works differently from other cancer treatments.
TAZVERIK® (tazemetostat) HCP | Advanced Epithelioid Sarcoma
TAZVERIK® (tazemetostat) is indicated for the treatment of adult patients with advanced epithelioid sarcoma. Review efficacy and safety data, dosing, or contact a rep. See Important Safety Information and full Prescribing Information, including Medication Guide.
How to Take TAZVERIK® (tazemetostat) for R/R Follicular …
TAZVERIK is a prescription medicine used to treat: Adults with follicular lymphoma when the disease has come back or did not respond to treatment, whose tumors have an abnormal EZH2 gene, and who have been treated with at least two prior medicines. Your healthcare provider will perform a test to make sure TAZVERIK is right for you.
Dosing for R/R Follicular Lymphoma | HCP - TAZVERIK
Recommended dosing for TAZVERIK® (tazemetostat), an oral, twice-daily tablet for patients with relapsed or refractory follicular lymphoma. Avoid coadministration of strong or moderate CYP3A inhibitors with TAZVERIK.
Relapsed or Refractory Follicular Lymphoma - TAZVERIK
TAZVERIK® (tazemetostat) is a prescription oral medicine for adults with relapsed or refractory follicular lymphoma. Find patient resources, study results, side effects, and how to take TAZVERIK. It is not known if TAZVERIK is safe and effective …
TAZVERIK® (tazemetostat) | Advanced Epithelioid Sarcoma
TAZVERIK® (tazemetostat) is a prescription oral medicine for adults 16+ with advanced epithelioid sarcoma. Find patient resources, study results, side effects, and how to take TAZVERIK. It is not known if TAZVERIK is safe and effective in children less than 16 years of age. See Important Safety Information and full Prescribing Information ...
TAZVERIK® (tazemetostat) | Mechanism of Action | HCP
TAZVERIK® (tazemetostat) inhibits EZH2 activity and may reduce B-cell proliferation associated with follicular lymphoma. TAZVERIK can cause serious side effects, including risk of new malignancies. See Important Safety Information and full Prescribing Information, including Medication Guide.